The market for cbd products has expanded rapidly over the past decade as pharmaceutical companies, nutraceutical manufacturers, wellness brands, and private-label businesses continue investing in cannabinoid-based innovations. From oils and capsules to beverages and finished dosage forms, CBD has become one of the most commercially important cannabinoids worldwide.
For B2B buyers, selecting reliable manufacturing partners and understanding market trends are essential for developing competitive product portfolios. As regulations evolve and consumer awareness increases, demand for high-quality cbd products is expected to remain strong across international markets.
This guide explores the latest market statistics, manufacturing opportunities, and formulation trends while highlighting the importance of scalable CBD production for pharmaceutical providers.
CBD Products Market Growth in 2026
The commercial success of cbd products is supported by continued global market expansion.
According to Grand View Research, the global cannabidiol (CBD) market was valued at USD 7.71 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of approximately 15.8% from 2024 to 2030. (grandviewresearch)
This sustained growth reflects increasing demand for pharmaceutical-grade CBD ingredients, finished formulations, and private-label cannabinoid solutions.
Why CBD Products Are in High Demand
Several factors continue driving demand for cbd products across healthcare and wellness industries.
Growing Consumer Awareness
Greater public understanding of cannabinoids has increased interest in CBD-based formulations worldwide.
Product Innovation
Manufacturers continue introducing new dosage forms and delivery technologies designed for pharmaceutical and nutraceutical markets.
Regulatory Progress
Many countries have established or are developing regulatory pathways for CBD products, creating new commercial opportunities for compliant manufacturers.
Expanding Research
Scientific research into cannabinoids continues to grow, encouraging further product development and investment.
A review published in the journal Molecules reported substantial growth in cannabinoid-related scientific publications during the past two decades. (mdpi)
CBD Products for B2B Manufacturing
For pharmaceutical companies and brand owners, cbd products represent a diverse portfolio of manufacturing opportunities.
Common product categories include:
- CBD oils
- CBD capsules
- CBD softgels
- CBD oral solutions
- CBD tinctures
- CBD gummies
- CBD topical formulations
- Finished dosage forms (FDF)
These product formats allow businesses to serve multiple healthcare and wellness segments while adapting to regional regulatory requirements.
CBD Infused Products Continue Expanding
Interest in cbd infused products continues to increase as manufacturers explore innovative delivery systems.
Examples include:
- Functional wellness products
- Nutritional supplements
- Topical formulations
- Cosmetic products
- Oral sprays
- Beverage ingredients
- Specialty formulations
Companies developing cbd infused products increasingly seek manufacturing partners capable of producing consistent, high-quality cannabinoid ingredients supported by comprehensive quality documentation.
CBD Drinks Wholesale Opportunities
The beverage sector represents one of the fastest-growing areas within the cannabinoid industry.
Demand for cbd drinks wholesale solutions continues to grow as beverage manufacturers investigate functional product categories incorporating cannabidiol.
Potential product formats include:
- Functional beverages
- Ready-to-drink formulations
- Beverage concentrates
- Water-soluble CBD ingredients
- Nutritional beverage supplements
Manufacturers entering the cbd drinks wholesale market require scalable production capabilities, formulation expertise, and regulatory compliance to support commercial success.
Scientific Support for CBD Products
The expanding popularity of cbd products is accompanied by continued scientific investigation.
The World Health Organization (WHO) concluded that pure cannabidiol generally demonstrates a favorable safety profile and that there is no evidence of abuse or dependence potential in humans. (who)
Additionally, the U.S. National Center for Biotechnology Information (NCBI) has published numerous reviews examining the pharmacology, chemistry, and therapeutic potential of cannabinoids.
These publications contribute to growing confidence in CBD research and encourage further investment in pharmaceutical development.
Manufacturing Considerations for CBD Products
Organizations sourcing cbd products should prioritize manufacturers capable of providing:
- GMP-oriented production
- Certificate of Analysis (CoA)
- Batch traceability
- Product consistency
- Regulatory documentation
- Scalable manufacturing
- International export support
Strong quality systems help ensure product reliability and facilitate successful market access across multiple jurisdictions.
Vonage Pharma’s CBD Category for Global Providers
Vonage Pharma supports pharmaceutical companies, nutraceutical manufacturers, distributors, and private-label brands through its specialized CBD category.
The portfolio includes products designed for international B2B customers, including:
- CBD API
- CBD Isolate
- CBD Distillate
- CBD Oil
- Water-Soluble CBD
- CBD FDF (Finished Dosage Forms)
- Customized cannabinoid formulations
Among these offerings, CBD FDF provides ready-to-commercialize dosage forms suitable for pharmaceutical and wellness applications.
Vonage Pharma manufactures CBD FDF in bulk quantities for providers seeking GMP-oriented manufacturing, international regulatory documentation, scalable production, and dependable long-term supply. By combining advanced manufacturing capabilities with rigorous quality standards, Vonage Pharma serves as a trusted partner for organizations seeking premium CBD solutions.
Future Outlook for CBD Products
The future of cbd products remains highly promising as research, regulation, and consumer demand continue evolving.
Several trends are expected to shape the market through 2026 and beyond:
- Continued global CBD market expansion
- Increasing pharmaceutical research
- Growth in private-label manufacturing
- Rising demand for premium cannabinoid ingredients
- Expansion of cbd infused products
- Increasing opportunities in cbd drinks wholesale
- Greater investment in finished dosage forms
As businesses continue expanding cannabinoid portfolios, reliable manufacturing partners become increasingly important.
Through its specialized CBD category and bulk CBD FDF manufacturing capabilities, Vonage Pharma supports pharmaceutical companies and brand owners with high-quality cannabinoid products designed for global B2B markets. Whether developing conventional CBD formulations or innovative next-generation cannabinoid products, organizations can benefit from scalable production, comprehensive quality systems, and dependable long-term manufacturing support.
